Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) vs National Center for Construction Safety and Health Research and Translation (U54)
Side-by-side comparison of two grants.
| Attribute | Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | National Center for Construction Safety and Health Research and Translation (U54) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $5.8M |
| Deadline | Closes 2027-02-11 | Closes 2026-12-01 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | Centers for Disease Control and Prevention - ERA |
| Who it's for | nonprofits, researchers | nonprofits, researchers, students |
noindex — no measured search demand